Neuphoria Therapeutics Inc (NEUP) — Cash Flow Quality Index

Latest as of December 2025: -3.45x

Neuphoria Therapeutics Inc (NEUP) has a Cash Flow Quality Index of -3.45x as of December 2025. Operating cash flow of $-6.44 Million is below net income of $1.86 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore NEUP cash generation efficiency to assess how effectively this company generates cash.

Cash Flow Quality Index

-3.45x

Operating CF / Net Income

Operating Cash Flow

$-6.44 Million

USD

Net Income

$1.86 Million

USD

Data as of

Dec 2025

Most recent filing

Annual Cash Flow Quality Index for Neuphoria Therapeutics Inc (None–None)

Year-by-year earnings quality comparison for Neuphoria Therapeutics Inc. For live market cap and the full company financial profile, see market value of Neuphoria Therapeutics Inc.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.